Non-alcoholic Fatty Liver Diseases (NAFLD) News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Nonalcoholic Fatty Liver Disease Improved With Exercise
TUESDAY, Feb. 28, 2023 -- Exercise is associated with a tripled likelihood of achieving a clinically meaningful treatment response for nonalcoholic fatty liver disease (NAFLD), according to a systematic review and meta-analysis published online Jan.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 28, 2023 Category: Pharmaceuticals Source Type: news

Intermittent Fasting Plus Exercise Aids Hepatic Steatosis
THURSDAY Feb. 23, 2023 -- Combining intermittent fasting with exercise is effective for reducing hepatic steatosis in patients with nonalcoholic fatty liver disease (NAFLD) but may not offer more benefit than fasting alone, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 23, 2023 Category: Pharmaceuticals Source Type: news

Fatty Liver Disease: Kids Get It, Too Fatty Liver Disease: Kids Get It, Too
Which children should be screened for NAFLD? And how do you get kids to forego sugar-sweetened beverages?The Cribsiders (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 22, 2023 Category: Consumer Health News Tags: Pediatrics Commentary Source Type: news

Fatty Liver Disease: Kids Get It Too Fatty Liver Disease: Kids Get It Too
Which children should be screened for NAFLD? And how do you get kids to forego sugar-sweetened beverages?The Cribsiders (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 22, 2023 Category: Gastroenterology Tags: Pediatrics Commentary Source Type: news

Screen High-Risk Individuals for NAFLD, Urges Guidance Screen High-Risk Individuals for NAFLD, Urges Guidance
Screening of high-risk individuals could identify asymptomatic cases and enable early intervention to prevent complications, experts write.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - February 17, 2023 Category: Endocrinology Tags: Gastroenterology News Source Type: news

Study: Alternate-day fasting may aid nonalcoholic fatty liver disease
Alternate-day fasting, combined with exercise, may help improve the health of patients with nonalcoholic fatty liver disease, researchers say. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 15, 2023 Category: Consumer Health News Source Type: news

Exercise Training Reduces Liver Fat in Patients With NAFLD Exercise Training Reduces Liver Fat in Patients With NAFLD
Exercise training can improve histologic response and liver fibrosis in patients with NAFLD.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 14, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Exercise Can Help Shed Dangerous Fat Around the Liver
MONDAY, Feb. 13, 2023 -- Often, patients with nonalcoholic fatty liver disease are advised to lose weight, but that can be hard to do and takes precious time. Now, researchers report they have found another strategy can help lower liver fat in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 13, 2023 Category: General Medicine Source Type: news

Environmental exposures underpin many metabolic diseases, expert says
<img width="100" src="https://factor.niehs.nih.gov/sites/niehs-factor/files/styles/large/public/2022/4/science-highlights/metabolic-diseases/thumb934755.jpg?itok=8CDXjH4i" /><br /><p>Lida Chatzi's NIEHS grant portfolio explores the origins of obesity, diabetes, non-alcoholic fatty liver disease, and cancer.</p> (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - February 3, 2023 Category: Environmental Health Source Type: news

Liver Stiffness Is a Predictor of All-cause Mortality in NAFLD Liver Stiffness Is a Predictor of All-cause Mortality in NAFLD
How accurate is vibration-controlled transient elastography as a tool for predicting mortality in NAFLD?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 2, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Supervised Exercise Keeps Diabetes at Bay a Decade Later
(MedPage Today) -- Supervised moderate and vigorous aerobic activity helped stave off type 2 diabetes in at-risk individuals with central obesity and nonalcoholic fatty liver disease, according to 10-year follow-up of a randomized trial from China... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 30, 2023 Category: Cardiology Source Type: news

Association of NAFLD Between Parents and Adolescent Children Association of NAFLD Between Parents and Adolescent Children
This study found that adolescent children with a parent with NAFLD were at increased risk of NAFLD.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 19, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche ’s Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial
Pivotal Phase III IMbrave050 study investigatingTecentriq plusAvastin in people with early-stage hepatocellular carcinoma (HCC) at high risk of recurrence following surgery met primary endpoint of recurrence-free survivalNew adjuvant treatments are urgently needed as an estimated 70-80% of people with early-stage HCC experience disease recurrence following surgery1Data will be discussed with health authorities globally, including the US Food and Drug Administration and the European Medicines Agency to inform the next regulatory steps, and presented at an upcoming medical meetingBasel, 19 January 2023 - Roche (SIX: RO, ROG;...
Source: Roche Investor Update - January 19, 2023 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche ’s Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial
Pivotal Phase III IMbrave050 study investigatingTecentriq plusAvastin in people with early-stage hepatocellular carcinoma (HCC) at high risk of recurrence following surgery met primary endpoint of recurrence-free survivalNew adjuvant treatments are urgently needed as an estimated 70-80% of people with early-stage HCC experience disease recurrence following surgery1Data will be discussed with health authorities globally, including the US Food and Drug Administration and the European Medicines Agency to inform the next regulatory steps, and presented at an upcoming medical meetingBasel, 19 January 2023 - Roche (SIX: RO, ROG;...
Source: Roche Media News - January 19, 2023 Category: Pharmaceuticals Source Type: news

Fast-Food Fans May Face Liver Damage
A study found that eating at least one-fifth of total daily calories from fast food can increase the risk of nonalcoholic fatty liver disease, a potentially life-threatening condition. (Source: WebMD Health)
Source: WebMD Health - January 13, 2023 Category: Consumer Health News Source Type: news